Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -3.975\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) O=C(c1ccc([N+](=O)[O-])cc1[N+](=O)[O-])N1CCCC1
(b) COCCCn1cnc2c(c1=O)c1nc3ccccc3nc1n2-c1ccccc1
(c) CN1CCc2c(OCC(=O)N3CCCc4ccccc43)cccc2C1=O
(d) Cc1cc2nc(-c3cc(N4CCOCC4)ccc3[N+](=O)[O-])ccn2n1
(e) Cc1ccn2cc(CNS(=O)(=O)c3ccc(Cl)s3)nc2c1
Answer: d. Cc1cc2nc(-c3cc(N4CCOCC4)ccc3[N+](=O)[O-])ccn2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc2nc(-c3cc(N4CCOCC4)ccc3[N+](=O)[O-])ccn2n1
Cc1cc2nc(-c3cc(N4CCOCC4)ccc3[N+](=O)[O-])ccn2n1
4-[3-(2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-4-nitrophenyl]morpholine